You are here

Ambryx

Fierce Biotech's Quarterly IPO and M&A Roundup: Q1'24

Fierce Biotech

Wed, 04/3/24 - 11:36 am

Kyverna Therapeutics

Contineum Therapeutics

CymaBay Therapeutics

Gilead Sciences

Fusion Pharmaceuticals

Merck's $303 Million Ambryx Deal Great For Investors

Seeking Alpha

Thu, 06/28/12 - 06:03 pm